These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17558132)

  • 1. Axonal neuropathy caused by epothilone B.
    Grewal RP
    Neurol India; 2007; 55(2):178-9. PubMed ID: 17558132
    [No Abstract]   [Full Text] [Related]  

  • 2. Epothilone-induced peripheral neuropathy: a review of current knowledge.
    Argyriou AA; Marmiroli P; Cavaletti G; Kalofonos HP
    J Pain Symptom Manage; 2011 Dec; 42(6):931-40. PubMed ID: 21621965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.
    Trivedi M; Budihardjo I; Loureiro K; Reid TR; Ma JD
    Future Oncol; 2008 Aug; 4(4):483-500. PubMed ID: 18684060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone.
    Goel S; Goldberg GL; Kuo DY; Muggia F; Arezzo J; Mani S
    Ann Oncol; 2008 Dec; 19(12):2048-52. PubMed ID: 18644829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epothilones: a novel class of non-taxane microtubule-stabilizing agents.
    Altaha R; Fojo T; Reed E; Abraham J
    Curr Pharm Des; 2002; 8(19):1707-12. PubMed ID: 12171542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone.
    Bosch-Barrera J; Espinós J; Gómez-Ibáñez A; Gállego Pérez-Larraya J; Iriarte J
    Clin Transl Oncol; 2009 Nov; 11(11):765-7. PubMed ID: 19917541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of peripheral neuropathy associated with chemotherapy in four oncology centers of Colombia.
    Martinez JW; Sanchez-Naranjo JC; Londono-De Los Rios PA; Isaza-Mejia CA; Sosa-Urrea JD; Martinez-Munoz MA; Lopez-Osorio JJ; Marin-Medina DS; Machado-Duque ME; Machado-Alba JE
    Rev Neurol; 2019 Aug; 69(3):94-98. PubMed ID: 31309998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epothilones: clinical update and future directions.
    Donovan D; Vahdat LT
    Oncology (Williston Park); 2008 Apr; 22(4):408-16; discussion 416, 421, 424 passim. PubMed ID: 18472615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
    Campone M; Berton-Rigaud D; Joly-Lobbedez F; Baurain JF; Rolland F; Stenzl A; Fabbro M; van Dijk M; Pinkert J; Schmelter T; de Bont N; Pautier P
    Oncologist; 2013; 18(11):1190-1. PubMed ID: 24105751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ixabepilone.
    Stein A
    Clin J Oncol Nurs; 2010 Feb; 14(1):65-71. PubMed ID: 20118028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMT2A: the name doesn't tell the whole story.
    Scherer SS
    Neurology; 2011 May; 76(20):1686-7. PubMed ID: 21508332
    [No Abstract]   [Full Text] [Related]  

  • 12. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute motor and sensory axonal neuropathy associated with Sjögren's syndrome.
    Ethemoglu O; Kocatürk Ö; Zeynep E
    Ideggyogy Sz; 2018 Sep; 71(9-10):352-356. PubMed ID: 30335268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.
    O'Connor OA; Portlock C; Moskowitz C; Straus D; Hamlin P; Stubblefield M; Dumetrescu O; Colevas AD; Grant B; Zelenetz A
    Br J Haematol; 2008 Oct; 143(2):201-9. PubMed ID: 18691173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice.
    Bruna J; Udina E; Alé A; Vilches JJ; Vynckier A; Monbaliu J; Silverman L; Navarro X
    Exp Neurol; 2010 Jun; 223(2):599-608. PubMed ID: 20188093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrylamide neuropathy: selective vulnerability of sensory fibers.
    Sumner AJ; Asbury AK
    Trans Am Neurol Assoc; 1974; 99():79-83. PubMed ID: 4377051
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiological mechanism of peripheral nervous system diseases induced by drug therapy].
    Kono Y; Nagata H
    Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1585-90. PubMed ID: 17802705
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone.
    Lee JJ; Low JA; Croarkin E; Parks R; Berman AW; Mannan N; Steinberg SM; Swain SM
    J Clin Oncol; 2006 May; 24(13):2084-91. PubMed ID: 16648510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.